Protective effects of BML-111 on cerulein-induced acute pancreatitis-associated lung injury via activation of Nrf2/ARE signaling pathway

Inflammation

Volumn 37, Issue 4, 2014, Pages 1120-1133

  Wang, Ying Zhen ^a   Zhang, You Cheng ^a   Cheng, Jun Sheng ^a   Ni, Qian ^a   Li, Pei Wu ^a   Han, Wei ^a   Zhang, Yu Long ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

acute pancreatitis associated lung injury; BML 111; Nrf2 ARE; severe acute pancreatitis

Indexed keywords

5(S),6(R)-7-TRIHYDROXYHEPTANOIC ACID, METHYL ESTER; CERULETIDE; HEME OXYGENASE 1; HEPTANOIC ACID DERIVATIVE; HMOX1 PROTEIN, MOUSE; LIPOPOLYSACCHARIDE; MALONALDEHYDE; MEMBRANE PROTEIN; NFE2L2 PROTEIN, MOUSE; NQO1 PROTEIN, MOUSE; PEROXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR NRF2;

ACUTE DISEASE; ACUTE LUNG INJURY; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; DISEASE MODEL; DNA RESPONSIVE ELEMENT; DRUG EFFECTS; LUNG; MALE; METABOLISM; MOUSE; PANCREATITIS; PATHOLOGY; SIGNAL TRANSDUCTION;

ACUTE DISEASE; ACUTE LUNG INJURY; ANIMALS; CERULETIDE; DISEASE MODELS, ANIMAL; HEME OXYGENASE-1; HEPTANOIC ACIDS; LIPOPOLYSACCHARIDES; LUNG; MALE; MALONDIALDEHYDE; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; NAD(P)H DEHYDROGENASE (QUINONE); NF-E2-RELATED FACTOR 2; PANCREATITIS; PEROXIDASE; RESPONSE ELEMENTS; SIGNAL TRANSDUCTION; SUPEROXIDE DISMUTASE;

EID: 84904766351     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-014-9836-y     Document Type: Article

References (39)

1. Papachristou, G.I. 2008. Prediction of severe acute pancreatitis: current knowledge and novel insights. World Journal of Gastroenterology 14: 6273-6275.
2. Bradley E.L. 3rd. 1993. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, GA, September 11 through 13, 1992. Archives of Surgery 128(5): 586-590.
3. Shen, H.N., and C.L. Lu. 2011. Incidence, resource use, and outcome of acute pancreatitis with/without intensive care: a nationwide population-based study in Taiwan. Pancreas 40: 10-15.
4. Andersson, R., B. Andersson, P. Haraldsen, et al. 2004. Incidence, management and recurrence rate of acute pancreatitis. Scandinavian Journal of Gastroenterology 39: 891-894. (Pubitemid 39215462)
5. Wang, X., Z. Cui, J. Zhang, et al. 2010. Early predictive factors of in hospital mortality in patients with severe acute pancreatitis. Pancreas 39: 114-115.
6. Barreto, S.G., and J. Rodrigues. 2008. Acute pancreatitis in Goa - a hospital-based study. J Indian Med Assoc 106: 575-576. 578.
7. Pereda, J., L. Sabater, L. Aparisi, et al. 2006. Interaction between cytokines and oxidative stress in acute pancreatitis. Current Medicinal Chemistry 13: 2775-2787. (Pubitemid 44509724)
8. Que, R.S., L.P. Cao, G.P. Ding, et al. 2010. Correlation of nitric oxide and other free radicals with the severity of acute pancreatitis and complicated systemic inflammatory response syndrome. Pancreas 39: 536-540.
9. Tsushima, K., L.S. King, N.R. Aggarwal, et al. 2009. Acute lung injury review. Internal Medicine 48: 621-630.
10. Blum, T., P. Maisonneuve, A.B. Lowenfels, et al. 2001. Fatal outcome in acute pancreatitis: its occurrence and early prediction. Pancreatology 1: 237-241. (Pubitemid 33674927)
11. De Campos, T., C. Cerqueira, L. Kuryura, et al. 2008. Morbimortality indicators in severe acute pancreatitis. JOP 9: 690-697.
12. Jeong, W.S., M. Jun, and A.N. Kong. 2006. Nrf2: a potential molecular target for cancer chemoprevention by natural compounds. Antioxidants and Redox Signaling 8: 99-106. (Pubitemid 43324535)
13. Copple, I.M., C.E. Goldring, N.R. Kitteringham, et al. 2010. The keap1-nrf2 cellular defense pathway: mechanisms of regulation and role in protection against drug-induced toxicity. Handbook of Experimental Pharmacology(233-266).
14. Chan, K.H., M.K. Ng, and R. Stocker. 2011. Haem oxygenase-1 and cardiovascular disease: mechanisms and therapeutic potential. Clin Sci (Lond) 120: 493-504.
15. Calkins, M.J., R.J. Jakel, D.A. Johnson, et al. 2005. Protection from mitochondrial complex II inhibition in vitro and in vivo by Nrf2-mediated transcription. Proceedings of the National Academy of Sciences of the United States of America 102: 244-249. (Pubitemid 40094460)
16. Chen, X.L., G. Dodd, S. Thomas, et al. 2006. Activation of Nrf2/ARE pathway protects endothelial cells from oxidant injury and inhibits inflammatory gene expression. American Journal of Physiology - Heart and Circulatory Physiology 290: H1862-H1870.
17. Chiang, N., M. Arita, and C.N. Serhan. 2005. Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX. Prostaglandins, Leukotrienes, and Essential Fatty Acids 73: 163-177. (Pubitemid 41253473)
18. Gong, J., S. Guo, H.B. Li, et al. 2012. BML-111, a lipoxin receptor agonist, protects haemorrhagic shock-induced acute lung injury in rats. Resuscitation 83: 907-912.
19. Zhang, L., X. Zhang, P. Wu, et al. 2008. BML-111, a lipoxin receptor agonist, modulates the immune response and reduces the severity of collagen-induced arthritis. Inflammation Research 57: 157-162. (Pubitemid 351601325)
20. Wang YZ, Zhang YC, Cheng JS, et al. 2013. BML-111, a lipoxin receptor agonist, ameliorates 'two-hit'-induced acute pancreatitis-associated lung injury in mice by the upregulation of heme oxygenase-1. Artif Cells Nanomed Biotechnol. [Epub ahead of print]
21. Zhang, L., J. Wan, H. Li, et al. 2007. Protective effects of BML-111, a lipoxin A(4) receptor agonist, on carbon tetrachloride-induced liver injury in mice. Hepatology Research 37: 948-956. (Pubitemid 47399924)
22. Hao, H., M. Liu, P. Wu, et al. 2011. Lipoxin A4 and its analog suppress hepatocellular carcinoma via remodeling tumor microenvironment. Cancer Letters 309: 85-94.
23. Schmidt, J., D.W. Rattner, K. Lewandrowski, et al. 1992. A better model of acute pancreatitis for evaluating therapy. Annals of Surgery 215: 44-56.
24. Hofbauer, B., A.K. Saluja, M. Bhatia, et al. 1998. Effect of recombinant platelet-activating factor acetylhydrolase on two models of experimental acute pancreatitis. Gastroenterology 115: 1238-1247. (Pubitemid 28485616)
25. Steer, M.L. 2001. Relationship between pancreatitis and lung diseases. Respiration Physiology 128: 13-16. (Pubitemid 32771687)
26. Pastor, C.M., M.A. Matthay, and J.L. Frossard. 2003. Pancreatitis- associated acute lung injury: new insights. Chest 124: 2341-2351. (Pubitemid 38010607)
27. Gong, J., H.B. Li, S. Guo, et al. 2012. Lipoxin receptor agonist, may be a potential treatment for hemorrhagic shock-induced acute lung injury. Medical Hypotheses 79: 92-94.
28. Chen, Y., H. Hao, S. He, et al. 2010. Lipoxin A4 and its analogue suppress the tumor growth of transplanted H22 in mice: the role of antiangiogenesis. Molecular Cancer Therapeutics 9: 2164-2174.
29. Hybertson, B.M., B. Gao, S.K. Bose, et al. 2011. Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation. Molecular Aspects of Medicine 32: 234-246.
30. Itoh, K., M. Mochizuki, Y. Ishii, et al. 2004. Transcription factor Nrf2 regulates inflammation by mediating the effect of 15-deoxy-Delta(12,14)- prostaglandin j(2). Molecular and Cellular Biology 24: 36-45. (Pubitemid 38010033)
31. Kikuchi, N., Y. Ishii, Y. Morishima, et al. 2010. Nrf2 protects against pulmonary fibrosis by regulating the lung oxidant level and Th1/Th2 balance. Respiratory Research 11: 31.
32. Bogaard, H.J., R. Natarajan, S.C. Henderson, et al. 2009. Chronic pulmonary artery pressure elevation is insufficient to explain right heart failure. Circulation 120: 1951-1960.
33. Yoon, H.Y., N.I. Kang, H.K. Lee, et al. 2008. Sulforaphane protects kidneys against ischemia-reperfusion injury through induction of the Nrf2-dependent phase 2 enzyme. Biochemical Pharmacology 75: 2214-2223.
34. Calvert, J.W., S. Jha, S. Gundewar, et al. 2009. Hydrogen sulfide mediates cardioprotection through Nrf2 signaling. Circulation Research 105: 365-374.
35. Satoh, T., K. Kosaka, K. Itoh, et al. 2008. Carnosic acid, a catechol-type electrophilic compound, protects neurons both in vitro and in vivo through activation of the Keap1/Nrf2 pathway via S-alkylation of targeted cysteines on Keap1. Journal of Neurochemistry 104: 1116-1131. (Pubitemid 351143643)
36. Kalayarasan, S., P.N. Prabhu, N. Sriram, et al. 2009. Diallyl sulfide enhances antioxidants and inhibits inflammation through the activation of Nrf2 against gentamicin-induced nephrotoxicity in Wistar rats. European Journal of Pharmacology 606: 162-171.
37. Sriram, N., S. Kalayarasan, and G. Sudhandiran. 2009. Epigallocatechin-3-gallate augments antioxidant activities and inhibits inflammation during bleomycin-induced experimental pulmonary fibrosis through Nrf2-Keap1 signaling. Pulmonary Pharmacology & Therapeutics 22: 221-236.
38. Jung, K.H., S.W. Hong, H.M. Zheng, et al. 2010. Melatonin ameliorates cerulein-induced pancreatitis by the modulation of nuclear erythroid 2-related factor 2 and nuclear factor-kappaB in rats. Journal of Pineal Research 48: 239-250.
39. Li, M., X. Zhang, L. Cui, et al. 2011. The neuroprotection of oxymatrine in cerebral ischemia/reperfusion is related to nuclear factor erythroid 2-related factor 2 (nrf2)-mediated antioxidant response: role of nrf2 and hemeoxygenase-1 expression. Biological and Pharmaceutical Bulletin 34: 595-601.